Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term experience with levetiracetam.

Bassel Abou-Khalil1, Barry Lazenby

  • 1Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-3375, United States. bassel.abou-khalil@mcmail.vanderbilt.edu

Epileptic Disorders : International Epilepsy Journal with Videotape
|August 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel epilepsy treatments in clinical development.

Epilepsy & behavior : E&B·2026
Same author

Focal to bilateral tonic-clonic seizures in newly diagnosed focal epilepsy.

Epilepsia·2025
Same author

Incidence of RINCH in pediatric EMU patients.

Epilepsy & behavior : E&B·2025
Same author

Risk of suicide and suicide-related events in subjects treated with antiseizure medications.

Expert review of neurotherapeutics·2024
Same author

Drug-resistant epilepsy: Definition, pathophysiology, and management.

Journal of the neurological sciences·2023
Same author

The cenobamate-clobazam interaction- evidence of synergy in addition to pharmacokinetic interaction.

Epilepsy & behavior : E&B·2023

Long-term studies confirm levetiracetam

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Short-term trials offer limited insight into long-term antiepileptic drug (AED) use.
  • Sustained efficacy and safety data are crucial for clinical practice.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of levetiracetam.
  • To assess levetiracetam's impact on treatment adherence and monotherapy potential.

Main Methods:

  • Analysis of long-term clinical trial data.
  • Review of post-marketing surveillance data.

Main Results:

  • Levetiracetam demonstrates sustained efficacy in seizure reduction over the long term.
  • The antiepileptic drug is well-tolerated, showing high retention and low withdrawal rates.

Related Experiment Videos

  • Patients may achieve seizure freedom or reduce concomitant AEDs, potentially transitioning to monotherapy.

    • Conclusions:

    • Levetiracetam offers sustained seizure control and favorable tolerability for long-term use.
    • It can be a valuable option for add-on therapy when additional seizure control is required.
    • Levetiracetam supports treatment adherence and may simplify medication regimens.